--2022/FY513.795M / 558.000M--
Hangzhou Huasu Technology
301157
Xinjiang Tianshan Animal Husbandry Bio-engineering
300313
ApicHope Pharmaceutical Group
300723
XINGANJIANG
873167
Sichuan Goldstone
300434
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Read more
No Data